Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Home
>
Blog
LATEST NEWS
Bacteria exposed to antiviral drugs develop antibiotic cross
A New Era of Antidepressants: Postpartum survivor speaks on new FDA
Respiratory Viral Infections The Next Frontier For Antiviral Drug Development
The Phase 1a/1b Human Clinical Trial of NV
Psychiatric Journals’ Pro
Jul 23, 2023
Bacteria exposed to antiviral drugs develop antibiotic cross
read more
Jul 22, 2023
A New Era of Antidepressants: Postpartum survivor speaks on new FDA
read more
Jul 21, 2023
Respiratory Viral Infections The Next Frontier For Antiviral Drug Development
read more
Jul 20, 2023
The Phase 1a/1b Human Clinical Trial of NV
read more
Jul 19, 2023
Psychiatric Journals’ Pro
read more
Jul 18, 2023
Science Update: Antiviral drug TEMPOL targets multiple SARS
read more
Jul 17, 2023
Antidepressants: I wasn't told about the side effects
read more
Jul 16, 2023
Antidepressants and side effects: How to know the cause
read more
Jul 15, 2023
FDA Approves First Pill for Postpartum Depression
read more
Jul 14, 2023
Postpartum Depression: Anti
read more
Jul 13, 2023
How Antidepressants Impact Diabetes
read more
Jul 12, 2023
Antidepressants for Postpartum Depression Could Mean Better Mental Health for Kids, Too
read more
first
3
4
5
6
7
8
9
last